A comparison of outcomes from a regional Mesothelioma MDT against the National Lung Cancer Audit ( NLCA) Mesothelioma standards

被引：0
|
作者：
Ahmed, Maryam [1 ]
Lyons, Judith [1 ]
Jackson, Susan [1 ]
Sharman, Anna [2 ]
Dixon, Mairead [3 ]
Taylor, Paul [3 ]
Holme, Jayne [1 ]
Evison, Matthew [1 ]
机构：
[1] Wythenshawe Hosp, Manchester Univ NHS Fdn Trust, Dept Resp Med, Manchester, Lancs, England
[2] Wythenshawe Hosp, Manchester Univ NHS Fdn Trust, Dept Radiol, Manchester, Lancs, England
[3] Wythenshawe Hosp, Manchester Univ NHS Fdn Trust, Dept Oncol, Manchester, Lancs, England
来源：
EUROPEAN RESPIRATORY JOURNAL | 2018年 / 52卷
关键词：
D O I：
10.1183/13993003.congress-2018.PA2889
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
PA2889
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Electricians' chrysotile asbestos exposure from electrical products and risks of mesothelioma and lung cancer
    Goodman, Julie E.
    Peterson, Michael K.
    Bailey, Lisa A.
    Kerper, Laura E.
    Dodge, David G.
    REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2014, 68 (01) : 8 - 15
  • [42] Erratum: Estimating the asbestos-related lung cancer burden from mesothelioma mortality
    V McCormack
    J Peto
    G Byrnes
    K Straif
    P Boffetta
    British Journal of Cancer, 2014, 111 : 2381 - 2381
  • [43] RESULTS FROM THE FIRST NATIONAL LUNG CANCER ORGANISATIONAL AUDIT
    Woolhouse, I. S.
    Meace, C.
    Greenway, K.
    Beckett, P.
    Peake, M. D.
    THORAX, 2014, 69 : A39 - A39
  • [44] Ninety-day mortality following lung cancer surgery: outcomes from the English national clinical outcomes audit
    Morgan, Helen
    Baldwin, David
    Hubbard, Richard
    Navani, Neal
    West, Doug
    O'Dowd, Emma Louise
    THORAX, 2022, 77 (07) : 724 - 726
  • [45] Influence of case-mix adjustment on outcomes in the National Lung Cancer Audit
    Woothouse, I.
    Beckett, R.
    Stanley, R. A.
    Peake, M. D.
    LUNG CANCER, 2010, 67 : S22 - S22
  • [46] DIAGNOSTIC AND PROGNOSTIC VALUE OF MESOTHELIN IN PATIENTS WITH MALIGNANT PLEURAL MESOTHELIOMA IN COMPARISON TO BENIGN ASBESTOSIS AND LUNG CANCER
    Muley, T.
    Hoffmann, H.
    Dienemann, H.
    Herth, F.
    Meister, M.
    Schneider, J.
    ANTICANCER RESEARCH, 2008, 28 (6B) : 4039 - 4039
  • [47] A Proposed System Toward Standardizing Surgical-Based Treatments for Malignant Pleural Mesothelioma, From the Joint National Cancer Institute-International Association for the Study of Lung Cancer-Mesothelioma Applied Research Foundation Taskforce
    Friedberg, Joseph S.
    Culligan, Melissa J.
    Tsao, Anne S.
    Rusch, Valerie
    Sepesi, Boris
    Pass, Harvey I.
    Bueno, Raphael
    Burt, Bryan
    Sugarbaker, David J.
    de Perrot, Marc
    Adjei, Alex A.
    Adusumilli, Prasad S.
    Hirsch, Fred R.
    Malik, Shakuntala M.
    Harpole, David J., Jr.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (08) : 1343 - 1353
  • [48] ASSESSMENT OF OPERABILITY IN EARLY STAGE LUNG CANCER: RESULTS FROM THE NATIONAL LUNG CANCER AUDIT
    Woolhouse, I.
    Stanley, R.
    Beckett, P.
    Peake, M. D.
    THORAX, 2010, 65 : A166 - A166
  • [49] Reply: Comment on ‘Estimating the asbestos-related lung cancer burden from mesothelioma mortality’
    V McCormack
    J Peto
    G Byrnes
    K Straif
    P Boffetta
    British Journal of Cancer, 2013, 109 : 825 - 826
  • [50] IMPROVING CURATIVE-INTENT TREATMENT RATES IN EARLY STAGE LUNG CANCER - RESULTS FROM 775 PATIENTS IN THE NLCA SPOTLIGHT AUDIT
    Navani, N.
    Harden, S.
    Khakwani, A.
    Wood, N.
    Woolhouse, I.
    Beckett, P.
    THORAX, 2018, 73 : A72 - A72
12345